Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 901–936
- Headlines
- 6390
- Sources here
- 7
- Companies here
- 37
Current section
Hong Kong financial news
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer
Marks Third NMPA Approval in China for an Ivonescimab-Containing Regimen NMPA Approval Based on HARMONi-6 Clinical Trial Conducted by Akeso in China Ivonescimab in Combination with Chemotherapy Is the First Known Regimen to Achieve a Statistically Significant Overall Survival Benefit over an Anti-PD-(L)1 Antibody …
9926
mentioned
Sharemaestro market context
Price below Trend Line
52 weeks -39.6% · Next-week setup positive 59.5%
Tesla's Model Y Loses China's Top Spot to Geely
This article first appeared on GuruFocus. Tesla Inc. (TSLA, Financials), the electric vehicle maker, lost the top spot among China's best-selling car models as lower-priced local competitors continue to gain ground. Warning! GuruFocus has detected 5 Warning Signs with TSLA. Is TSLA fairly valued? …
Sharemaestro market context Price below Trend Line 52 weeks -22.8%